BRSYFPNKHealthcare

BrainsWay Ltd.

Reports in 15d· 2026-05-12

+17.4% · 90d

$13.55

+0.00 (+0.00%)

News

No News Yet

Press releases and SEC filings for BRSYF will appear here as they are published.

Check back later for updates

Key Data

Market Cap$542.4M

Open$13.54

Prev Close$13.55

Day Range$13.54 – $13.55

52W Range$3.40 – $13.55

Volume300

P/E (TTM)75.28

EPS$0.18

Dividend Yield—

Beta0.14

Profit Margin14.51%

Revenue Growth27.40%

Next Earnings2026-05-12(15d)

About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Healthcare · Medical Devices

www.brainsway.com

Top Institutional Holders

As of 2025-12-31 · prior 2025-09-30

Valor Management LLC$50.5M

2,657,475 sh+26.3%

MASTERS CAPITAL MANAGEMENT LLC$19.0M

1,000,000 sh0.0%

ARK Investment Management LLC$2.4M

127,331 sh● NEW

Y.D. More Investments Ltd$2.2M

114,962 sh+559.8%

ESSEX INVESTMENT MANAGEMENT CO LLC$5.8M

304,180 sh-2.1%

See all holders →